![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, April 18, 2022 10:09:03 AM
Revive Therapeutics (unofficial)
@revivethera
Interesting study from
@japan
via
. #Bucillamine does not interfere with vaccine antibodies unlike most other Rheumatoid drugs studied. https://bit.ly/37qaHsu $RVV $RVVTF
Interesting study from @japan via @Reddit. #Bucillamine does not interfere with vaccine antibodies unlike most other Rheumatoid drugs studied. https://t.co/PTK0rX30CA $RVV $RVVTF #COVID
— Revive Therapeutics (unofficial) (@revivethera) April 17, 2022
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM